Infiltration of blood outgrowth endothelial cells into tumor spheroids: Role of matrix metalloproteinases and irradiation

Anticancer Research

Volumn 27, Issue 3 B, 2007, Pages 1415-1421

  Wei, Jiwu ^a   Zhou, Shaoxia ^b   Bachem, Max Georg ^b   Debatin, Klaus Michael ^a   Beltinger, Christian ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Blood outgrowth endothelial cell; Irradiation; Matrix metalloproteinase

Indexed keywords

EDETIC ACID; MATRIX METALLOPROTEINASE;

ANIMAL CELL; ARTICLE; CANCER CELL; CELL INFILTRATION; CONTROLLED STUDY; DRUG INHIBITION; ENDOTHELIUM CELL; ENZYME RELEASE; FIBROBLAST; GAMMA IRRADIATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IRRADIATION; LEWIS CARCINOMA; LOW DRUG DOSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SPHEROID; UPREGULATION; ZYMOGRAPHY;

ANIMALS; BLOOD CELLS; CELL MOVEMENT; EDETIC ACID; ENDOTHELIAL CELLS; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; PARACRINE COMMUNICATION; RADIATION; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 34249288336     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M and Isner JM: Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85: 221-228, 1999.
2. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, Witte L, Wu Y, Hicklin D, Zhu Z, Hackett NR, Crystal RG, Moore MA, Hajjar KA, Manova K, Benezra R and Rafii S: Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 7: 1194-1201, 2001.
3. Jodele S, Chantrain CF, Blavier L, Lutzko C, Crooks GM, Shimada H, Coussens LM and Declerck YA: The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent. Cancer Res 65: 3200-3208, 2005.
4. Ferrari N, Glod J, Lee J, Kobiler D and Fine HA: Bone marrow-derived, endothelial progenitor-like cells as angiogenesis-selective gene-targeting vectors. Gene Ther 10: 647-656, 2003.
5. Wei J, Blum S, Unger M, Jarmy G, Lamparter M, Geishauser A, Vlastos GA, Chan G, Fischer KD, Rattat D, Debatin KM, Hatzopoulos AK and Beltinger C: Embryonic endothelial progenitor cells armed with a suicide gene target hypoxic lung metastases after intravenous delivery. Cancer Cell 5: 477-488, 2004.
6. Wei J, Jarmy G, Genuneit J, Debatin KM and Beltinger C: Human blood late outgrowth endothelial progenitors for gene therapy of cancer: determinants of efficacy. Gene Ther 4: 344-356, 2007.
7. Jevremovic D, Gulati R, Hennig I, Diaz RM, Cole C, Kleppe L, Cosset FL, Simari RD and Vile RG: Use of blood outgrowth endothelial cells as virus-producing vectors for gene delivery to tumors. Am J Physiol Heart Circ Physiol 287: H494-500, 2004.
8. Jarmy G, Wei J, Debatin KM and Beltinger C: Apoptosis-inducing cellular vehicles for cancer gene therapy: endothelial and neural progenitors. In: Apoptosis, Cell Signaling and Human Diseases: Molecular Mechanisms. Srivastava R (ed.). Totowa, Humana Press, Inc. USA, Vol. I, pp. 279-320, 2006.
9. Gothert JR, Gustin SE, van Eekelen JA, Schmidt U, Hall MA, Jane SM, Green AR, Gottgens B, Izon DJ and Begley CG: Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium. Blood 104: 1769-1777, 2004.
10. Lynch CC and Matrisian LM: Matrix metalloproteinases in tumor-host cell communication. Differentiation 70: 561-573, 2002.
11. Rundhaug JE: Matrix metalloproteinases and angiogenesis. J Cell Mol Med 9: 267-285, 2005.
12. Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H and Itohara S: Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 58: 1048-1051, 1998.
13. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z and Hanahan D: Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2: 737-744, 2000.
14. Fang J, Shing Y, Wiederschain D, Yan L, Butterfield C, Jackson G, Harper J, Tamvakopoulos G and Moses MA: Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proc Natl Acad Sci USA 97: 3884-3889, 2000.
15. Mira E, Lacalle RA, Buesa JM, de Buitrago GG, Jimenez-Baranda S, Gomez-Mouton C, Martinez AC and Manes S: Secreted MMP9 promotes angiogenesis more efficiently than constitutive active MMP9 bound to the tumor cell surface. J Cell Sci 117: 1847-1857, 2004.
16. Wild-Bode C, Weller M, Rimner A, Dichgans J and Wick W: Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res 61: 2744-2750, 2001.
17. Kaliski A, Maggiorella L, Cengel KA, Mathe D, Rouffiac V, Opolon P, Lassau N, Bourhis J and Deutsch E: Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion. Mol Cancer Ther 4: 1717-1728, 2005.
18. Heissig B, Rafii S, Akiyama H, Ohki Y, Sato Y, Rafael T, Zhu Z, Hicklin DJ, Okumura K, Ogawa H, Werb Z and Hattori K: Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization. J Exp Med 202: 739-750, 2005.
19. Tabatabai G, Frank B, Mohle R, Weller M and Wick W: Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-beta-dependent HIF-1alpha-mediated induction of CXCL12. Brain 129: 2426-2435, 2006.
20. Haug C, Lenz C and Bachem MG: Oxidized LDL inhibit hepatocyte growth factor synthesis in coronary smooth muscle cells. Int J Cardiol 103: 298-306, 2005.
21. Coussens LM, Tinkle CL, Hanahan D and Werb Z: MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103: 481-490, 2000.